收稿日期: 2024-11-15
网络出版日期: 2025-02-19
基金资助
国家自然科学基金青年科学基金项目(82203361)
Regulatory effects and mechanisms of exosomes derived from stem cells and macrophages on colitis
Received date: 2024-11-15
Online published: 2025-02-19
刘苡佳 , 刘斌 , 胡奎 , 陈颜芳 , 蔡德 . 干细胞和巨噬细胞来源的外泌体对结肠炎的调控作用及其机制[J]. 实用医学杂志, 2025 , 41(3) : 447 -453 . DOI: 10.3969/j.issn.1006-5725.2025.03.022
Colitis is a common inflammatory bowel disease whose pathogenesis is related to immune regulation and intestinal microbial homeostasis. Exosomes are membrane vesicles secreted by cells that contain proteins， lipids， and other substances. Stem cells and macrophages can participate in the regulation of related diseases by secreting exosomes. It has been found that exosomes of stem cell and macrophage origin are closely involved in the regulation of colitis， and exosomes derived from stem cells， especially mesenchymal stem cells， play an important role in anti-colitis. This article reviews the role and possible mechanisms of mesenchymal stem cell-based and macrophage-derived exosomes in the regulation of colitis， aiming to provide ideas for in-depth study of colitis and new strategies for its treatment.
Key words： exosome; colitis; mesenchymal stem cell; macrophage
| 1 | MARION-LETELLIER R， SAVOYE G， GHOSH S. IBD： In Food We Trust［J］. J Crohns Colitis， 2023，17（1）：149. |
| 2 | ROGLER G， SINGH A， KAVANAUGH A， et al. Extraintestinal Manifestations of Inflammatory Bowel Disease： Current Concepts， Treatment， and Implications for Disease Management［J］. Gastroenterology， 2021，161（4）：1118-1132. doi:10.1053/j.gastro.2021.07.042 |
| 3 | CARON B， HONAP S， PEYRIN-BIROULET L. Epidemiology of Inflammatory Bowel Disease across the Ages in the Era of Advanced Therapies［J］. J Crohns Colitis， 2024，18（）：ii3-ii15. doi:10.1093/ecco-jcc/jjae082 |
| 4 | RUDRAPRASAD D， RAWAT A， JOSEPH J. Exosomes， extracellular vesicles and the eye［J］. Exp Eye Res， 2022，214：108892. doi:10.1016/j.exer.2021.108892 |
| 5 | LEE K M， SEO E C， LEE J H， et al. The Multifunctional Protein Syntenin-1： Regulator of Exosome Biogenesis， Cellular Function， and Tumor Progression［J］. Int J Mol Sci， 2023，24（11）：9418. doi:10.3390/ijms24119418 |
| 6 | YE L， LI Y， ZHANG S， et al. Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression［J］. Cytokine Growth F R， 2023，73：27-39. doi:10.1016/j.cytogfr.2023.05.002 |
| 7 | YANG D， ZHANG W， ZHANG H， et al. Progress， opportunity， and perspective on exosome isolation-efforts for efficient exosome-based theranostics［J］. Theranostics， 2020，10（8）：3684-3707. doi:10.7150/thno.41580 |
| 8 | BEHERA J， KUMAR A， VOOR M J， et al. Exosomal lncRNA-H19 promotes osteogenesis and angiogenesis through mediating Angpt1/Tie2-NO signaling in CBS-heterozygous mice［J］. Theranostics， 2021，11（16）：7715-7734. doi:10.7150/thno.58410 |
| 9 | KIMIZ-GEBOLOGLU I， ONCEL S S. Exosomes： Large-scale production， isolation， drug loading efficiency， and biodistribution and uptake［J］. J Control Release， 2022，347：533-543. doi:10.1016/j.jconrel.2022.05.027 |
| 10 | MONDAL J， PILLARISETTI S， JUNNUTHULA V， et al. Hybrid exosomes， exosome-like nanovesicles and engineered exosomes for therapeutic applications［J］. J Control Release， 2023，353：1127-1149. doi:10.1016/j.jconrel.2022.12.027 |
| 11 | KRYLOVA S V， FENG D. The Machinery of Exosomes： Biogenesis， Release， and Uptake［J］. Int J Mol Sci， 2023，24（2）：1337. doi:10.3390/ijms24021337 |
| 12 | CHAN B D， WONG W Y， LEE M M， et al. Exosomes in Inflammation and Inflammatory Disease［J］. Proteomics， 2019，19（8）：e1800149. doi:10.1002/pmic.201800149 |
| 13 | YANG Y， PENG Y， LI Y， et al. Role of stem cell derivatives in inflammatory diseases［J］. Front Immunol， 2023，14：1153901. doi:10.3389/fimmu.2023.1153901 |
| 14 | GHAFOURI-FARD S， NIAZI V， HUSSEN B M， et al. The Emerging Role of Exosomes in the Treatment of Human Disorders With a Special Focus on Mesenchymal Stem Cells-Derived Exosomes［J］. Front Cell Dev Biol， 2021，9：653296. doi:10.3389/fcell.2021.653296 |
| 15 | GUPTA S， SARANGI P P. Inflammation driven metabolic regulation and adaptation in macrophages［J］. Clin Immunol， 2023，246：109216. doi:10.1016/j.clim.2022.109216 |
| 16 | HARRELL C R， JOVICIC N， DJONOV V， et al. Therapeutic Use of Mesenchymal Stem Cell-Derived Exosomes： From Basic Science to Clinics［J］. Pharmaceutics， 2020，12（5）：474. doi:10.3390/pharmaceutics12050474 |
| 17 | DING J Y， CHEN M J， WU L F， et al. Mesenchymal stem cell-derived extracellular vesicles in skin wound healing： roles， opportunities and challenges［J］. Mil Med Res， 2023，10（1）：36. doi:10.1186/s40779-023-00472-w |
| 18 | HIGASHIYAMA M， HOKARI R. New and Emerging Treatments for Inflammatory Bowel Disease［J］. Digestion， 2023，104（1）：74-81. doi:10.1159/000527422 |
| 19 | WANG C， XU M， FAN Q， et al. Therapeutic potential of exosome-based personalized delivery platform in chronic inflammatory diseases［J］. Asian J Pharm Sci， 2023，18（1）：100772. doi:10.1016/j.ajps.2022.100772 |
| 20 | WANG X， ZHOU G， ZHOU W， et al. Exosomes as a New Delivery Vehicle in Inflammatory Bowel Disease［J］. Pharmaceutics， 2021，13（10）：1644. doi:10.3390/pharmaceutics13101644 |
| 21 | NOONIN C， THONGBOONKERD V. Exosome-inflammasome crosstalk and their roles in inflammatory responses［J］. Theranostics， 2021，11（9）：4436-4451. doi:10.7150/thno.54004 |
| 22 | WEI S， WU X， CHEN M， et al. Exosomal-miR-129-2-3p derived from Fusobacterium nucleatum-infected intestinal epithelial cells promotes experimental colitis through regulating TIMELESS-mediated cellular senescence pathway［J］. Gut Microbes， 2023，15（1）：2240035. doi:10.1080/19490976.2023.2240035 |
| 23 | LI DF， YANG MF， XU J， et al. Extracellular Vesicles： The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease［J］. Int J Nanomedicine， 2022，17：3893-3911. doi:10.2147/ijn.s370784 |
| 24 | FABIáN O， KAMARADOVá K. Morphology of inflammatory bowel diseases （IBD） ［J］. Cesk Patol， 2022，58（1）：27-37. |
| 25 | SAEZ A， HERRERO-FERNANDEZ B， GOMEZ-BRIS R， et al. Pathophysiology of Inflammatory Bowel Disease： Innate Immune System［J］. Int J Mol Sci， 2023，24（2）：1526. doi:10.3390/ijms24021526 |
| 26 | DANNE C， SKERNISKYTE J， MARTEYN B， et al. Neutrophils： from IBD to the gut microbiota［J］. Nat Rev Gastro Hepat， 2024，21（3）：184-197. doi:10.1038/s41575-023-00871-3 |
| 27 | EINAV L， HIRSCH A， RON Y， et al. Risk Factors for Malnutrition among IBD Patients［J］. Nutrients， 2021，13（11）：4098. doi:10.3390/nu13114098 |
| 28 | VAN EATON J， HATCH Q M. Surgical Emergencies in Inflammatory Bowel Disease［J］. Surg Clin North Am， 2024，104（3）：685-699. doi:10.1016/j.suc.2023.11.012 |
| 29 | SHAH S C， ITZKOWITZ S H. Colorectal Cancer in Inflammatory Bowel Disease： Mechanisms and Management［J］.Gastroenterology，2022，162（3）：715-730.e3. doi:10.1053/j.gastro.2021.10.035 |
| 30 | YASMIN F， NAJEEB H， SHAIKH S， et al. Novel drug delivery systems for inflammatory bowel disease［J］. World J Gastroenterol， 2022，28（18）：1922-1933. doi:10.3748/wjg.v28.i18.1922 |
| 31 | MUZAMMIL M A， FARIHA F， PATEL T， et al. Advancements in Inflammatory Bowel Disease： A Narrative Review of Diagnostics， Management， Epidemiology， Prevalence， Patient Outcomes， Quality of Life， and Clinical Presentation［J］. Cureus， 2023，15（6）：e41120. |
| 32 | TRIANTAFILLIDIS J K， ZOGRAFOS C G， KONSTADOULAKIS M M， et al. Combination treatment of inflammatory bowel disease： Present status and future perspectives［J］. World J Gastroentero， 2024，30（15）：2068-2080. doi:10.3748/wjg.v30.i15.2068 |
| 33 | SEMENOVA E， GRUDNIAK M P， MACHAJ E K， et al. Mesenchymal Stromal Cells from Different Parts of Umbilical Cord： Approach to Comparison & Characteristics［J］. Stem Cell Rev Rep， 2021，17（5）：1780-1795. doi:10.1007/s12015-021-10157-3 |
| 34 | MEBARKI M， ABADIE C， LARGHERO J， et al. Human umbilical cord-derived mesenchymal stem/stromal cells： A promising candidate for the development of advanced therapy medicinal products［J］. Stem Cell Res Ther， 2021，12（1）：152. doi:10.1186/s13287-021-02222-y |
| 35 | HEIDARI N， ABBASI-KENARSARI H， NAMAKI S， et al. Regulation of the Th17/Treg balance by human umbilical cord mesenchymal stem cell-derived exosomes protects against acute experimental colitis［J］. Exp Cell Res， 2022，419（1）：113296. doi:10.1016/j.yexcr.2022.113296 |
| 36 | CAI X， ZHANG Z Y， YUAN J T， et al. hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p/NLRP3 axis［J］. Stem Cell Res Ther， 2021，12（1）：416. doi:10.1186/s13287-021-02492-6 |
| 37 | WANG J， PEI B， YAN J， et al. hucMSC-Derived Exosomes Alleviate the Deterioration of Colitis via the miR-146a/SUMO1 Axis［J］. Mol Pharm， 2022，19（2）：484-493. doi:10.1021/acs.molpharmaceut.1c00450 |
| 38 | XU Y， TANG X， FANG A， et al. HucMSC-Ex carrying miR-203a-3p.2 ameliorates colitis through the suppression of caspase11/4-induced macrophage pyroptosis［J］. Int Immunopharmacol， 2022，110：108925. doi:10.1016/j.intimp.2022.108925 |
| 39 | SHEN Q， HUANG Z， YAO J， et al. Extracellular vesicles-mediated interaction within intestinal microenvironment in inflammatory bowel disease［J］. J Adv Res， 2021，37：221-233. doi:10.1016/j.jare.2021.07.002 |
| 40 | YANG S， LIANG X， SONG J， et al. A novel therapeutic approach for inflammatory bowel disease by exosomes derived from human umbilical cord mesenchymal stem cells to repair intestinal barrier via TSG-6［J］. Stem Cell Res Ther， 2021，12（1）：315. doi:10.1186/s13287-021-02404-8 |
| 41 | LIANG X， LI C， SONG J， et al. HucMSC-Exo Promote Mucosal Healing in Experimental Colitis by Accelerating Intestinal Stem Cells and Epithelium Regeneration via Wnt Signaling Pathway［J］. Int J Nanomed， 2023，18：2799-2818. doi:10.2147/ijn.s402179 |
| 42 | WEI Z， HANG S， WIREDU OCANSEY D K， et al. Human umbilical cord mesenchymal stem cells derived exosome shuttling mir-129-5p attenuates inflammatory bowel disease by inhibiting ferroptosis［J］. J Nanobiotechnol， 2023，21（1）：188. doi:10.1186/s12951-023-01951-x |
| 43 | BUNNELL B A. Adipose Tissue-Derived Mesenchymal Stem Cells［J］. Cells， 2021，10（12）：3433. doi:10.3390/cells10123433 |
| 44 | LEE J H， L?TVALL J， CHO B S. The Anti-Inflammatory Effects of Adipose Tissue Mesenchymal Stem Cell Exosomes in a Mouse Model of Inflammatory Bowel Disease［J］. Int J Mol Sci， 2023，24（23）：16877. doi:10.3390/ijms242316877 |
| 45 | HEIDARI N， ABBASI-KENARSARI H， NAMAKI S， et al. Adipose-derived mesenchymal stem cell-secreted exosome alleviates dextran sulfate sodium-induced acute colitis by Treg cell induction and inflammatory cytokine reduction［J］. J Cell Physiol， 2021，236（8）：5906-5920. doi:10.1002/jcp.30275 |
| 46 | SHAPOURI-MOGHADDAM A， MOHAMMADIAN S， VAZINI H， et al. Macrophage plasticity， polarization， and function in health and disease［J］. J Cell Physiol， 2018，233（9）：6425-6440. doi:10.1002/jcp.26429 |
| 47 | KADOMOTO S， IZUMI K， MIZOKAMI A. Macrophage Polarity and Disease Control［J］. Int J Mol Sci， 2021，23（1）：144. doi:10.3390/ijms23010144 |
| 48 | QIAN W， HUANG L， XU Y， et al. Hypoxic ASCs-derived Exosomes Attenuate Colitis by Regulating Macrophage Polarization via miR-216a-5p/HMGB1 Axis ［J］. Inflamm Bowel Dis， 2023，29（9）：1515. doi:10.1093/ibd/izad101 |
| 49 | HEO JS， KIM S. Human adipose mesenchymal stem cells modulate inflammation and angiogenesis through exosomes［J］. Sci Rep， 2022，12（1）：2776. doi:10.1038/s41598-022-06824-1 |
| 50 | CHU D T， PHUONG T N T， TIEN N L B， et al. An Update on the Progress of Isolation， Culture， Storage， and Clinical Application of Human Bone Marrow Mesenchymal Stem/Stromal Cells［J］. Int J Mol Sci， 2020，21（3）：708. doi:10.3390/ijms21030708 |
| 51 | ZHU F， WEI C， WU H， et al. Hypoxic mesenchymal stem cell-derived exosomes alleviate ulcerative colitis injury by limiting intestinal epithelial cells reactive oxygen species accumulation and DNA damage through HIF-1α［J］. Int Immunopharmacol， 2022，113（Pt A）：109426. doi:10.1016/j.intimp.2022.109426 |
| 52 | YANG J， LIU XX， FAN H， et al. Extracellular Vesicles Derived from Bone Marrow Mesenchymal Stem Cells Protect against Experimental Colitis via Attenuating Colon Inflammation， Oxidative Stress and Apoptosis［J］. PLoS One， 2015，10（10）：e0140551. doi:10.1371/journal.pone.0140551 |
| 53 | LIU H， LIANG Z， WANG F， et al. Exosomes from mesenchymal stromal cells reduce murine colonic inflammation via a macrophage-dependent mechanism［J］. JCI Insight， 2019，4（24）：e131273. doi:10.1172/jci.insight.131273 |
| 54 | SUN D， CAO H， YANG L， et al. MiR-200b in heme oxygenase-1-modified bone marrow mesenchymal stem cell-derived exosomes alleviates inflammatory injury of intestinal epithelial cells by targeting high mobility group box 3［J］. Cell Death Dis， 2020，11（6）：480. doi:10.1038/s41419-020-2685-8 |
| 55 | CHU S， YU T， WANG W， et al. Exosomes derived from EphB2-overexpressing bone marrow mesenchymal stem cells regulate immune balance and repair barrier function［J］. Biotechnol Lett， 2023，45（5-6）：601-617. doi:10.1007/s10529-023-03358-y |
| 56 | TIAN J， ZHU Q， ZHANG Y， et al. Olfactory Ecto-Mesenchymal Stem Cell-Derived Exosomes Ameliorate Experimental Colitis via Modulating Th1/Th17 and Treg Cell Responses［J］. Front Immunol， 2020，11：598322. doi:10.3389/fimmu.2020.598322 |
| 57 | CHANG Y， ZHANG Y， JIANG Y， et al. From Hair to Colon： Hair Follicle-Derived MSCs Alleviate Pyroptosis in DSS-Induced Ulcerative Colitis by Releasing Exosomes in a Paracrine Manner［J］. Oxid Med Cell Longev， 2022，2022：9097530. doi:10.1155/2022/9097530 |
| 58 | DENG C， ZHANG H， LI Y， et al. Exosomes derived from mesenchymal stem cells containing berberine for ulcerative colitis therapy［J］. J Colloid Interface Sci， 2024，671：354-373. doi:10.1016/j.jcis.2024.05.162 |
| 59 | YANG R， LIAO Y， WANG L， et al. Exosomes Derived From M2b Macrophages Attenuate DSS-Induced Colitis［J］. Front Immunol， 2019，10：2346. doi:10.3389/fimmu.2019.02346 |
| 60 | DENG F， YAN J， LU J， et al. M2 Macrophage-Derived Exosomal miR-590-3p Attenuates DSS-Induced Mucosal Damage and Promotes Epithelial Repair via the LATS1/YAP/ β-Catenin Signalling Axis［J］. J Crohns Colitis， 2021，15（4）：665-677. doi:10.1093/ecco-jcc/jjaa214 |
| 61 | LU H， SUO Z， LIN J， et al. Monocyte-macrophages modulate intestinal homeostasis in inflammatory bowel disease［J］. Biomark Res， 2024，12（1）：76. doi:10.1186/s40364-024-00612-x |
| 62 | YIP J L K， BALASURIYA G K， SPENCER S J， et al. The Role of Intestinal Macrophages in Gastrointestinal Homeostasis： Heterogeneity and Implications in Disease［J］. Cell Mol Gastroenter， 2021，12（5）：1701-1718. doi:10.1016/j.jcmgh.2021.08.021 |
| 63 | DU R， CHEN S， HAN C， et al. M1 intestinal macrophages-derived exosomes promote colitis progression and mucosal barrier injury［J］. Aging （Albany NY）， 2024，16（6）：5703-5710. doi:10.18632/aging.205672 |
| 64 | LU J， LIU D， TAN Y， et al. M1 Macrophage exosomes MiR-21a-5p aggravates inflammatory bowel disease through decreasing E-cadherin and subsequent ILC2 activation［J］. J Cell Mol Med， 2021，25（6）：3041-3050. doi:10.1111/jcmm.16348 |
| 65 | CHANG X， SONG Y H， XIA T， et al. Macrophage-derived exosomes promote intestinal mucosal barrier dysfunction in inflammatory bowel disease by regulating TMIGD1 via mircroRNA-223［J］. Int Immunopharmacol， 2023，121：110447. doi:10.1016/j.intimp.2023.110447 |
| 66 | ABDOLMOHAMMADI K， MAHMOUDI T， ALIMOHAMMADI M， et al. Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation［J］. Life Sci， 2023，312：121206. doi:10.1016/j.lfs.2022.121206 |
| 67 | HEGARTY L M， JONES G R， BAIN C C. Macrophages in intestinal homeostasis and inflammatory bowel disease［J］. Nat Rev Gastro Hepat， 2023，20（8）：538-553. doi:10.1038/s41575-023-00769-0 |
| 68 | LI D F， TANG Q， YANG M F， et al. Plant-derived exosomal nanoparticles： potential therapeutic for inflammatory bowel disease［J］. Nanoscale Adv， 2023，5（14）：3575-3588. doi:10.1039/d3na00093a |
| 69 | CAI Y， ZHANG L， ZHANG Y， et al. Plant-Derived Exosomes as a Drug-Delivery Approach for the Treatment of Inflammatory Bowel Disease and Colitis-Associated Cancer［J］. Pharmaceutics， 2022，14（4）：822. doi:10.3390/pharmaceutics14040822 |
| 70 | ZHU Z， LIAO L， GAO M， et al. Garlic-derived exosome-like nanovesicles alleviate dextran sulphate sodium-induced mouse colitis via the TLR4/MyD88/NF-κB pathway and gut microbiota modulation［J］. Food Funct， 2023，14（16）：7520-7534. doi:10.1039/d3fo01094e |
| 71 | KIM J， ZHANG S， ZHU Y， et al. Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppression of inflammatory cytokines［J］. J Ginseng Res， 2023，47（5）：627-637. doi:10.1016/j.jgr.2023.01.004 |
| 72 | KANG M， KANG M， LEE J， et al. Allium tuberosum-derived nanovesicles with anti-inflammatory properties prevent DSS-induced colitis and modify the gut microbiome［J］. Food Funct， 2024，15（14）：7641-7657. doi:10.1039/d4fo01366b |
| 73 | ZHU M Z， XU H M， LIANG Y J， et al. Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion［J］. J Nanobiotechnol， 2023，21（1）：309. doi:10.1186/s12951-023-02065-0 |
| 74 | SRIWASTVA M K， DENG Z B， WANG B， et al. Exosome-like nanoparticles from Mulberry bark prevent DSS-induced colitis via the AhR/COPS8 pathway［J］. EMBO Rep， 2022，23（3）：e53365. doi:10.15252/embr.202153365 |
| 75 | NAZARI H， ALBORZI F， HEIRANI-TABASI A， et al. Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in IBD patients： clinical trial phase I［J］. Gastroenterol Rep （Oxf）， 2022，10：goac075. doi:10.1093/gastro/goac075 |
| 76 | HADIZADEH A， AKBARI-ASBAGH R， HEIRANI-TABASI A， et al. Localized Administration of Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Refractory Perianal Fistula in Crohn's Disease Patients： A Phase II Clinical Trial［J］. Dis Colon Rectum， 2024，67（12）：p 1564-1575. doi:10.1097/dcr.0000000000003502 |
| 77 | CLUA-FERRé L， SUAU R， VA?ó-SEGARRA I， et al. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles： A focus on inflammatory bowel disease［J］. Clin Transl Med， 2024，14（11）：e70075. doi:10.1002/ctm2.70075 |
| 78 | GAN J， SUN L， CHEN G， et al. Mesenchymal Stem Cell Exosomes Encapsulated Oral Microcapsules for Acute Colitis Treatment［J］. Adv Healthc Mater， 2022，11（17）：e2201105. doi:10.1002/adhm.202201105 |
| 79 | DENG C， HU Y， CONCEI??O M， et al. Oral delivery of layer-by-layer coated exosomes for colitis therapy［J］. J Control Release， 2023，354：635-650. doi:10.1016/j.jconrel.2023.01.017 |
/
| 〈 |
|
〉 |